Co-Authors
This is a "connection" page, showing publications co-authored by Evangelos Giamarellos-Bourboulis and Konstantina Katrini.
Connection Strength
1.621
-
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021 10; 27(10):1752-1760.
Score: 0.241
-
Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial. Infect Dis Ther. 2021 Dec; 10(4):2333-2351.
Score: 0.240
-
An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
Score: 0.233
-
Reply to Radermacher et al. on "Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus". Shock. 2021 01 01; 55(1):139-140.
Score: 0.230
-
A novel optical biosensor for the early diagnosis of sepsis and severe Covid-19: the PROUD study. BMC Infect Dis. 2020 Nov 19; 20(1):860.
Score: 0.229
-
Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus. Shock. 2020 11; 54(5):633-637.
Score: 0.228
-
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host Microbe. 2020 06 10; 27(6):992-1000.e3.
Score: 0.220